EUVIMEDEUVIMED entdecken
ValidierungsstudieMultizentrische Studie

Validation study on the 2 mm diameter cutoff in lymph node‐positive cases following radical prostatectomy in accordance with the AJCC / UICC TNM 8th edition: Real‐world data analysis from a Japanese cohort

Masashi Kato iD, Masaki Shiota iD, Takahiro Kimura, Ryoichi Hanazawa, Akihiro Hirakawa, Dai Takamatsu, Kojiro Tashiro, Yoshiyuki Matsui, Katsuyoshi Hashine, Ryoichi Saito iD, Akira Yokomizo iD, Yoshiyuki Yamamoto und 9 weitere

International Journal of Urology · 2024

DOI: 10.1111/iju.15434 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift International Journal of Urology, 2024. Verfasst von Masashi Kato und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nagoya University, Nagoya, Japan. Hauptthemen laut MEDLINE: Prostatectomy, Prostatic Neoplasms, Lymphatic Metastasis, Neoplasm Staging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) 8th edition has proposed micrometastasis as a lymph node metastasis (LN+) of diameter ≤2 mm in prostate cancer. However, supporting evidence has not described. We evaluated LN+ patients' survival after radical prostatectomy (RP) based on the LN maximum tumor diameter (MTD).

Methods

Data from 561 LN+ patients after RP and pelvic LN dissection (PLND) treated between 2006 and 2019 at 33 institutions were retrospectively investigated. Patients were stratified by a LN+ MTD cutoff of 2 mm. Outcomes included castration resistance‐free survival (CRFS), metastasis‐free survival (MFS), cancer‐specific survival (CSS), and overall survival (OS).

Results

In total, 282 patients were divided into two groups (LN+ MTD >2 mm [ n = 206] and ≤2 mm [ n = 76]). Patients of LN+ status >2 mm exhibited significantly decreased CRFS and MFS, and poorer CSS and OS. No patients developed CRPC in the LN+ status ≤2 mm group when the PLND number was ≥14. Multivariate analysis showed the number of LN removed, RP Gleason pattern 5, and MTD in LN+ significantly predicted CRFS.

Conclusions

Patients of LN+ status ≤2 mm showed better prognoses after RP. In all the patients in the ≤2‐mm group, the progression to CRPC could be prevented with appropriate interventions, particularly when PLND is performed accurately. Our findings support the utility of the pN substaging proposed by the AJCC/UICC 8th edition; this will facilitate precision medicine for patients with advanced prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatectomyProstatic NeoplasmsLymphatic MetastasisNeoplasm StagingLymph Node ExcisionLymph NodesHumansMaleAgedMiddle AgedRetrospective StudiesJapanNeoplasm MicrometastasisPrognosisEast Asian People

Stichwörter der Autor:innen

AJCC/UICC 8th editionlymph node metastasismicrometastasisprostate cancerradical prostatectomy

Autor:innen und Institutionen

  • Department of Urology, Nagoya University, Nagoya, Japan.
  • Department of Urology, Kyushu University, Fukuoka, Japan.
  • Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Department of Clinical Biostatistics, Graduate School of Medical and Dental Science, Tokyo Medical and Dental University, Tokyo, Japan.
  • Department of Urology, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.

ORCID-Profile: Masashi Kato, Masaki Shiota, Ryoichi Saito, Akira Yokomizo, Hiroaki Matsumoto, Shusuke Akamatsu, Toyonori Tsuzuki

Zitieren

APA

Kato, M., Shiota, M., Kimura, T., Hanazawa, R., Hirakawa, A., Takamatsu, D., Tashiro, K., Matsui, Y., Hashine, K., Saito, R., Yokomizo, A., Yamamoto, Y., Narita, S., Hashimoto, K., Matsumoto, H., Akamatsu, S., Nishiyama, N., Eto, M., Kitamura, H., …, & Japanese Urological Oncology Group (2024). Validation study on the 2 mm diameter cutoff in lymph node‐positive cases following radical prostatectomy in accordance with the AJCC / UICC TNM 8th edition: Real‐world data analysis from a Japanese cohort. International Journal of Urology. https://doi.org/10.1111/iju.15434

Vancouver

Kato M, Shiota M, Kimura T, Hanazawa R, Hirakawa A, Takamatsu D, et al. Validation study on the 2 mm diameter cutoff in lymph node‐positive cases following radical prostatectomy in accordance with the AJCC / UICC TNM 8th edition: Real‐world data analysis from a Japanese cohort. International Journal of Urology. 2024. doi:10.1111/iju.15434

BibTeX
@article{Kato2024,
  author = {Kato, Masashi and Shiota, Masaki and Kimura, Takahiro and Hanazawa, Ryoichi and Hirakawa, Akihiro and Takamatsu, Dai and Tashiro, Kojiro and Matsui, Yoshiyuki and Hashine, Katsuyoshi and Saito, Ryoichi and Yokomizo, Akira and Yamamoto, Yoshiyuki and Narita, Shintaro and Hashimoto, Kohei and Matsumoto, Hiroaki and Akamatsu, Shusuke and Nishiyama, Naotaka and Eto, Masatoshi and Kitamura, Hiroshi and Tsuzuki, Toyonori and Japanese Urological Oncology Group, Japanese Urological Oncology Group},
  title = {Validation study on the 2 mm diameter cutoff in lymph node‐positive cases following radical prostatectomy in accordance with the AJCC / UICC TNM 8th edition: Real‐world data analysis from a Japanese cohort},
  journal = {International Journal of Urology},
  year = {2024},
  doi = {10.1111/iju.15434}
}
Kostenlos starten →